NO177793C - Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten - Google Patents
Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåtenInfo
- Publication number
- NO177793C NO177793C NO882917A NO882917A NO177793C NO 177793 C NO177793 C NO 177793C NO 882917 A NO882917 A NO 882917A NO 882917 A NO882917 A NO 882917A NO 177793 C NO177793 C NO 177793C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- nucleic acid
- well
- host cell
- fusion protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868626148A GB8626148D0 (en) | 1986-11-01 | 1986-11-01 | Antigen presentation & purification system |
GB878708531A GB8708531D0 (en) | 1987-04-09 | 1987-04-09 | Fusion proteins & particles |
US07/036,807 US5041385A (en) | 1986-11-01 | 1987-04-10 | Vector expressing fusion proteins and particles |
PCT/GB1987/000764 WO1988003563A1 (en) | 1986-11-01 | 1987-10-28 | Fusion proteins and particles |
Publications (4)
Publication Number | Publication Date |
---|---|
NO882917D0 NO882917D0 (no) | 1988-06-30 |
NO882917L NO882917L (no) | 1988-08-29 |
NO177793B NO177793B (no) | 1995-08-14 |
NO177793C true NO177793C (no) | 1995-11-22 |
Family
ID=27263194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO882917A NO177793C (no) | 1986-11-01 | 1988-06-30 | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0330661B1 (no) |
JP (2) | JP2708046B2 (no) |
AU (1) | AU606896B2 (no) |
CA (1) | CA1339263C (no) |
DE (1) | DE3788807T2 (no) |
ES (1) | ES2010231A6 (no) |
NO (1) | NO177793C (no) |
WO (1) | WO1988003563A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0329671B1 (en) * | 1986-11-01 | 1994-01-12 | British Bio-Technology Limited | Particulate hybrid hiv antigens |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
US5631154A (en) * | 1988-06-10 | 1997-05-20 | Therion Biologics, Incorporated | Self assembled, defective, non-self-propagating lentivirus particles |
US5747324A (en) * | 1988-06-10 | 1998-05-05 | Therion Biologics Corporation | Self-assembled, defective, non-self-propagating lentivirus particles |
AU4665389A (en) * | 1988-11-23 | 1990-06-12 | Regents Of The University Of California, The | Position-specific insertion vectors and method of using same |
JPH04500308A (ja) * | 1989-05-17 | 1992-01-23 | リサーチ・コーポレーション・テクノロジーズ・インコーポレーテッド | 組換え型生成物のレトロウィルス媒介分泌 |
EP0474868B1 (en) * | 1989-05-30 | 1996-11-13 | Nippon Zeon Co., Ltd. | Method of producing core structure of retro virus and particle produced thereby |
JP3034025B2 (ja) * | 1989-06-01 | 2000-04-17 | アプライド・バイオテクノロジー・インコーポレーテツド | 自己アセンブルド欠損非自己増殖性ウイルス粒子 |
WO1991019803A1 (en) * | 1990-06-19 | 1991-12-26 | Applied Biotechnology, Incorporated | Self assembled, defective, nonself-propagating viral particles |
GB9107631D0 (en) * | 1991-04-10 | 1991-05-29 | British Bio Technology | Proteinaceous particles |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
FR2703996B1 (fr) * | 1993-04-16 | 1995-07-21 | Transgene Sa | Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote. |
US7476517B2 (en) | 1999-06-30 | 2009-01-13 | Evotec Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
US20040014033A1 (en) | 1999-06-30 | 2004-01-22 | Evotec Biosystems Ag, A Corporation Of Germany | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
DE60034947T2 (de) * | 1999-06-30 | 2008-01-24 | Evotec Ag | Virusähnliche partikel, vorbereitung und verwendung in screening und funktionelle genomanwendung |
EP1219705B1 (en) * | 2000-12-29 | 2007-11-28 | Evotec AG | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
FI116198B (fi) | 2001-07-16 | 2005-10-14 | Valtion Teknillinen | Polypeptidien immobilisointimenetelmä |
LT5414B (lt) | 2005-04-13 | 2007-04-25 | Biotechnologijos Institutas | Monokloninių antikūnų gavimo būdas, hibridomos, gautos šiuo būdu ir rekombinantinės chimerinės į virusus panašios dalelės su įterptais kitų baltymų fragmentais kaip imunogenai hibridomų gavimui šiuo būdu |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
JPS6193199A (ja) * | 1984-10-13 | 1986-05-12 | Kyowa Hakko Kogyo Co Ltd | 抗インタ−フエロン−γモノクロ−ナル抗体 |
-
1987
- 1987-10-28 JP JP62506664A patent/JP2708046B2/ja not_active Expired - Fee Related
- 1987-10-28 WO PCT/GB1987/000764 patent/WO1988003563A1/en active IP Right Grant
- 1987-10-28 EP EP87906926A patent/EP0330661B1/en not_active Expired - Lifetime
- 1987-10-28 AU AU81057/87A patent/AU606896B2/en not_active Ceased
- 1987-10-28 DE DE3788807T patent/DE3788807T2/de not_active Expired - Fee Related
- 1987-10-30 ES ES878703105A patent/ES2010231A6/es not_active Expired
- 1987-10-30 CA CA000550668A patent/CA1339263C/en not_active Expired - Fee Related
-
1988
- 1988-06-30 NO NO882917A patent/NO177793C/no not_active IP Right Cessation
-
1996
- 1996-05-23 JP JP8128724A patent/JPH09248191A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2010231A6 (es) | 1989-11-01 |
AU8105787A (en) | 1988-06-01 |
NO882917L (no) | 1988-08-29 |
DE3788807D1 (de) | 1994-02-24 |
JP2708046B2 (ja) | 1998-02-04 |
JPH09248191A (ja) | 1997-09-22 |
NO177793B (no) | 1995-08-14 |
NO882917D0 (no) | 1988-06-30 |
EP0330661A1 (en) | 1989-09-06 |
WO1988003563A1 (en) | 1988-05-19 |
AU606896B2 (en) | 1991-02-21 |
EP0330661B1 (en) | 1994-01-12 |
DE3788807T2 (de) | 1994-06-30 |
JPH02501026A (ja) | 1990-04-12 |
CA1339263C (en) | 1997-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO177793C (no) | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten | |
NO177794C (no) | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten | |
NO175715C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive aminosyrederivater, samt mellomprodukter ved fremstilling av disse | |
DK110885A (da) | Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf | |
IT7921838A0 (it) | Processo di rivelazione e di caratterizzazione di un acido nucleico o di una sua sequenza e reattivo enzimatico per la realizzazione di questo processo. | |
NO871785L (no) | Fremgangsmaate for fremstilling av et proteinprodukt samt vektorsystem for fremgangsmaatens utfoerelse. | |
DK374087A (da) | Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne | |
NO964445L (no) | DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA | |
NZ221790A (en) | Method for the continuous production of a heterologous protein in a eukaryotic host cell | |
ATE158816T1 (de) | Expression von pace in wirtszellen und verfahren zu dessen verwendung | |
DK158659C (da) | 2,4,6-triiod-isophthalsyrederivater, deres fremstilling og roentgenkontrastmidler indeholdende disse. | |
AU587989B2 (en) | DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins | |
ZA864525B (en) | Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained | |
NO179109C (no) | Ekspresjonsvektor, rekombinante vertsceller samt fremgangsmåte for fremstilling av terapeutisk aktivt, rekombinant CSF | |
DK388789D0 (da) | Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna | |
IT8520036A0 (it) | Processo per la preparazione biotecnologica di acidi alfa-arilalcanoici otticamente attivi. | |
DK534286A (da) | Nicotinsyrederivater, deres fremstilling og anvendelse som herbicider samt mellemprodukter ved fremstillingen og disses fremstilling | |
DK124787A (da) | Peptider indeholdende op til 8-aminosyregrupperinger og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen | |
DK354188D0 (da) | Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen | |
WO1994025590A3 (en) | Trichohyalin and transglutaminase-3 and methods of using same | |
DK94385D0 (da) | Proteiner, farmaceutiske praeparater, gener, vektorer, vaertsorganismer samt fremgangsmaader til deres fremstilling | |
NO874573D0 (no) | Nucleinsyreprober for paavisning av latent humant cytomegalovirus i lodprodukter. | |
AU5945386A (en) | Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin | |
NO178036C (no) | Fremgangsmåte for fremstilling av fusjonsproteiner, genstruktur, vektorer streptomycetceller og fusjonsproteinene | |
AU6521186A (en) | Lytic viruses as expression vectors, host cell containing same and process for protein production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2003 |